chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy; Red rash; Arm swelled up; Very red; Hot; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelled up), ERYTHEMA (Very red ), FEELING HOT (Hot), ERYTHEMA (Redness) and VACCINATION SITE PRURITUS (Itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported ).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm swelled up), ERYTHEMA (Very red ), FEELING HOT (Hot), ERYTHEMA (Redness) and VACCINATION SITE RASH (Red rash). On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy). On 26-Jan-2021, PERIPHERAL SWELLING (Arm swelled up) had resolved. At the time of the report, ERYTHEMA (Very red ), FEELING HOT (Hot), ERYTHEMA (Redness), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE RASH (Red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported   Treatment using   acetaminophen was reported Usage of ice was reported   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Pain in extremity, Vaccination site reaction
Clinical narrative: really bad reaction; left breast swelled up so bad; arm was in a lot of pain; A spontaneous report was received from other healthcare professional concerning herself a 51-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events really bad reaction, left breast swelled up so bad, arm was in a lot of pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 041L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) really bad reaction, left breast swelled up so bad, arm was in a lot of pain, and she was scheduled to get the second dose today 05 Feb 2021. She had to get lab work done to make sure there was no infection; everything so far was ok.  Treatment details included Not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), really bad reaction, left breast swelled up so bad, arm was in a lot of pain were not recovered or not resolved.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Pinkish area where the shot was given, hot, itchy; Pinkish area where the shot was given, hot, itchy; Pinkish area where the shot was given, hot, itchy; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pinkish area where the shot was given, hot, itchy.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 16 Jan 2021, 9 days prior to the onset of the events pinkish area where the shot was given, hot, itchy, the patient received dose of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  On 24 Jan 2021, the patient started getting a pinkish area where the shot was given. It was hot and itchy.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the events pinkish area where the shot was given, hot, itchy were not reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Head discomfort, Nausea, Pyrexia
Clinical narrative: His head is hurting so bad to the point where he can't lay down; Diarrhea; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (His head is hurting so bad to the point where he can't lay down), DIARRHOEA (Diarrhea), PYREXIA (Fever) and NAUSEA (Nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (His head is hurting so bad to the point where he can't lay down), DIARRHOEA (Diarrhea), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, HEAD DISCOMFORT (His head is hurting so bad to the point where he can't lay down), DIARRHOEA (Diarrhea), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Illness, Nausea, Pyrexia
Clinical narrative: sick; Fever; Joint pain; Extreme nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), PYREXIA (Fever), ARTHRALGIA (Joint pain), NAUSEA (Extreme nausea) and FATIGUE (Fatigue) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick), PYREXIA (Fever), ARTHRALGIA (Joint pain), NAUSEA (Extreme nausea) and FATIGUE (Fatigue). At the time of the report, ILLNESS (sick), PYREXIA (Fever), ARTHRALGIA (Joint pain), NAUSEA (Extreme nausea) and FATIGUE (Fatigue) outcome was unknown.      No treatment information was provided. No relevant concomitant medications reported.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-021006, US-MODERNATX, INC.-MOD-2021-021085, US-MODERNATX, INC.-MOD-2021-022730, US-MODERNATX, INC.-MOD-2021-021736 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-021006:Crosslinked (MOD21-021976) US-MODERNATX, INC.-MOD-2021-021085:Crosslinked (MOD21-021921) US-MODERNATX, INC.-MOD-2021-022730:Crosslinked (MOD21-021803) US-MODERNATX, INC.-MOD-2021-021736:Crosslinked (MOD21-022005)
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Diarrhoea, Inflammation, Rash erythematous
Clinical narrative: started feel like sleepy after receiving the vaccine; cough, inflamed, diarrhea; cough, inflamed, diarrhea; cough, inflamed, diarrhea; woke up with a rash on the chest, it's itchy; running nose, weakness, cough, and a red rash; running nose, weakness, cough, and a red rash; running nose, weakness, cough, and a red rash; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (started feel like sleepy after receiving the vaccine), COUGH (cough, inflamed, diarrhea), INFLAMMATION (cough, inflamed, diarrhea), DIARRHOEA (cough, inflamed, diarrhea) and RASH PRURITIC (woke up with a rash on the chest, it's itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D2 for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (started feel like sleepy after receiving the vaccine), COUGH (cough, inflamed, diarrhea), INFLAMMATION (cough, inflamed, diarrhea), DIARRHOEA (cough, inflamed, diarrhea), RASH PRURITIC (woke up with a rash on the chest, it's itchy), RHINORRHOEA (running nose, weakness, cough, and a red rash), ASTHENIA (running nose, weakness, cough, and a red rash) and RASH ERYTHEMATOUS (running nose, weakness, cough, and a red rash). At the time of the report, SOMNOLENCE (started feel like sleepy after receiving the vaccine), COUGH (cough, inflamed, diarrhea), INFLAMMATION (cough, inflamed, diarrhea), DIARRHOEA (cough, inflamed, diarrhea), RASH PRURITIC (woke up with a rash on the chest, it's itchy), RHINORRHOEA (running nose, weakness, cough, and a red rash), ASTHENIA (running nose, weakness, cough, and a red rash) and RASH ERYTHEMATOUS (running nose, weakness, cough, and a red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Rhinorrhoea, Somnolence
Clinical narrative: started feel like sleepy after receiving the vaccine; cough, inflamed, diarrhea; cough, inflamed, diarrhea; cough, inflamed, diarrhea; woke up with a rash on the chest, it's itchy; running nose, weakness, cough, and a red rash; running nose, weakness, cough, and a red rash; running nose, weakness, cough, and a red rash; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (started feel like sleepy after receiving the vaccine), COUGH (cough, inflamed, diarrhea), INFLAMMATION (cough, inflamed, diarrhea), DIARRHOEA (cough, inflamed, diarrhea) and RASH PRURITIC (woke up with a rash on the chest, it's itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D2 for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (started feel like sleepy after receiving the vaccine), COUGH (cough, inflamed, diarrhea), INFLAMMATION (cough, inflamed, diarrhea), DIARRHOEA (cough, inflamed, diarrhea), RASH PRURITIC (woke up with a rash on the chest, it's itchy), RHINORRHOEA (running nose, weakness, cough, and a red rash), ASTHENIA (running nose, weakness, cough, and a red rash) and RASH ERYTHEMATOUS (running nose, weakness, cough, and a red rash). At the time of the report, SOMNOLENCE (started feel like sleepy after receiving the vaccine), COUGH (cough, inflamed, diarrhea), INFLAMMATION (cough, inflamed, diarrhea), DIARRHOEA (cough, inflamed, diarrhea), RASH PRURITIC (woke up with a rash on the chest, it's itchy), RHINORRHOEA (running nose, weakness, cough, and a red rash), ASTHENIA (running nose, weakness, cough, and a red rash) and RASH ERYTHEMATOUS (running nose, weakness, cough, and a red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Red rash at site of injection, lasting 5-6 days; A spontaneous report was received from a consumer concerning a 39-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red rash at site of injection.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 23 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient experienced the event red rash at site of injection.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, red rash at site of injection was resolved in 5-6 days.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema
Clinical narrative: having red arm that is hurting badly; having red arm that is hurting badly; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (having red arm that is hurting badly) and VACCINATION SITE ERYTHEMA (having red arm that is hurting badly) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039L20A and 039L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (having red arm that is hurting badly) and VACCINATION SITE ERYTHEMA (having red arm that is hurting badly). At the time of the report, PAIN IN EXTREMITY (having red arm that is hurting badly) and VACCINATION SITE ERYTHEMA (having red arm that is hurting badly) had resolved.            No concomitant medications provided No treatment medications provided   This case was linked to MOD-2021-021737 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: updated Events outcome  (Unknown to Resolved) patient denied for the follow up
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Dizziness, Hyperhidrosis
Clinical narrative: Sweating; Lethargy; Dizziness; Diarrhea; Aches; Chills; Fever (100.9°F); A spontaneous report  was received from a consumer concerning a 74-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 025J20-2A) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the events- chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness. Lab data performed on the same day included body temperature:100.9 F (high).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events- chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness - were unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Pain, Pyrexia
Clinical narrative: Sweating; Lethargy; Dizziness; Diarrhea; Aches; Chills; Fever (100.9°F); A spontaneous report  was received from a consumer concerning a 74-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 025J20-2A) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the events- chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness. Lab data performed on the same day included body temperature:100.9 F (high).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events- chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness - were unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site joint swelling, Pruritus, Rash, Rash pustular
Clinical narrative: scratches self raw; pustules; bad rash along back; croissant-sized rash on left buttock; Injection site armpit swelling, it moved down to Patient's right side; itchy; bright red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy), ERYTHEMA (bright red), SCRATCH (scratches self raw) and RASH PUSTULAR (pustules) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy) and ERYTHEMA (bright red). On 08-Feb-2021, the patient experienced RASH (croissant-sized rash on left buttock). On an unknown date, the patient experienced SCRATCH (scratches self raw), RASH PUSTULAR (pustules) and RASH (bad rash along back). The patient was treated with CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy), ERYTHEMA (bright red), SCRATCH (scratches self raw), RASH PUSTULAR (pustules), RASH (croissant-sized rash on left buttock) and RASH (bad rash along back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, SARS-CoV-2 test: (Negative) negative for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  Treatment medications includes ice and benadryl
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Scratch
Clinical narrative: scratches self raw; pustules; bad rash along back; croissant-sized rash on left buttock; Injection site armpit swelling, it moved down to Patient's right side; itchy; bright red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy), ERYTHEMA (bright red), SCRATCH (scratches self raw) and RASH PUSTULAR (pustules) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy) and ERYTHEMA (bright red). On 08-Feb-2021, the patient experienced RASH (croissant-sized rash on left buttock). On an unknown date, the patient experienced SCRATCH (scratches self raw), RASH PUSTULAR (pustules) and RASH (bad rash along back). The patient was treated with CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy), ERYTHEMA (bright red), SCRATCH (scratches self raw), RASH PUSTULAR (pustules), RASH (croissant-sized rash on left buttock) and RASH (bad rash along back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, SARS-CoV-2 test: (Negative) negative for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  Treatment medications includes ice and benadryl
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Sore arm; still a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PAIN (still a little sore) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and PAIN (still a little sore). At the time of the report, PAIN IN EXTREMITY (Sore arm) and PAIN (still a little sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient went to doctor the day before getting the shot and doctor prescribed  Zpack & eyedrops for sinus/allergies.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: TCR appended on 12-JUL-2021 included outcome of the events.
Sex: U
Vaccine: COVID19
Symptoms: Impaired work ability
Clinical narrative: someone from the nursing home couldn't go to work; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (someone from the nursing home couldn't go to work) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced IMPAIRED WORK ABILITY (someone from the nursing home couldn't go to work). At the time of the report, IMPAIRED WORK ABILITY (someone from the nursing home couldn't go to work) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-018604, MOD-2021-016700 (Patient Link).   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Nausea, Pain in extremity
Clinical narrative: Woke up soaking wet; Had to urinate every 10-15 minutes which occurred for about 2 hours; whole upper arm was super sore; Felt so Nauseated; Chills; Head felt like it was going to blow up; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Woke up soaking wet), URINE ABNORMALITY (Had to urinate every 10-15 minutes which occurred for about 2 hours), PAIN IN EXTREMITY (whole upper arm was super sore), NAUSEA (Felt so Nauseated) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HYPERHIDROSIS (Woke up soaking wet), URINE ABNORMALITY (Had to urinate every 10-15 minutes which occurred for about 2 hours), PAIN IN EXTREMITY (whole upper arm was super sore), NAUSEA (Felt so Nauseated), CHILLS (Chills) and HEADACHE (Head felt like it was going to blow up). At the time of the report, HYPERHIDROSIS (Woke up soaking wet), URINE ABNORMALITY (Had to urinate every 10-15 minutes which occurred for about 2 hours), PAIN IN EXTREMITY (whole upper arm was super sore), NAUSEA (Felt so Nauseated), CHILLS (Chills) and HEADACHE (Head felt like it was going to blow up) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications include Blood thinners No treatment medications provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Urine abnormality
Clinical narrative: Woke up soaking wet; Had to urinate every 10-15 minutes which occurred for about 2 hours; whole upper arm was super sore; Felt so Nauseated; Chills; Head felt like it was going to blow up; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Woke up soaking wet), URINE ABNORMALITY (Had to urinate every 10-15 minutes which occurred for about 2 hours), PAIN IN EXTREMITY (whole upper arm was super sore), NAUSEA (Felt so Nauseated) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HYPERHIDROSIS (Woke up soaking wet), URINE ABNORMALITY (Had to urinate every 10-15 minutes which occurred for about 2 hours), PAIN IN EXTREMITY (whole upper arm was super sore), NAUSEA (Felt so Nauseated), CHILLS (Chills) and HEADACHE (Head felt like it was going to blow up). At the time of the report, HYPERHIDROSIS (Woke up soaking wet), URINE ABNORMALITY (Had to urinate every 10-15 minutes which occurred for about 2 hours), PAIN IN EXTREMITY (whole upper arm was super sore), NAUSEA (Felt so Nauseated), CHILLS (Chills) and HEADACHE (Head felt like it was going to blow up) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications include Blood thinners No treatment medications provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Rash, Rash erythematous
Clinical narrative: Red rash; Pain on top of arm to the elbow/arm hurt; Tired; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on top of arm to the elbow/arm hurt), FATIGUE (Tired), RASH (Rash) and RASH ERYTHEMATOUS (Red rash) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on top of arm to the elbow/arm hurt), FATIGUE (Tired) and RASH (Rash). On 19-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash). At the time of the report, PAIN IN EXTREMITY (Pain on top of arm to the elbow/arm hurt), FATIGUE (Tired) and RASH (Rash) was resolving and RASH ERYTHEMATOUS (Red rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included Cortisone cream to treat her symptoms.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: No new information.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore arm at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced INJECTION SITE PAIN (Sore arm at the injection site). At the time of the report, INJECTION SITE PAIN (Sore arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness, Myalgia, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Hurts to raise arm; Neck is stiff; Body aches; Arm hurts; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Hurts to raise arm), MUSCULOSKELETAL STIFFNESS (Neck is stiff), MYALGIA (Body aches), VACCINATION SITE PAIN (Arm hurts) and HEADACHE (Headaches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Hurts to raise arm), MUSCULOSKELETAL STIFFNESS (Neck is stiff), MYALGIA (Body aches), VACCINATION SITE PAIN (Arm hurts) and HEADACHE (Headaches). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Hurts to raise arm), MUSCULOSKELETAL STIFFNESS (Neck is stiff), MYALGIA (Body aches), VACCINATION SITE PAIN (Arm hurts) and HEADACHE (Headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20 Apr 2021. Updated reporter's email. On 02-Jun-2021: Follow up received on 02 Jun 2021. Updated outcome of the events.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Rapid heartbeat that lasted for 6 to 10 seconds; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid heartbeat that lasted for 6 to 10 seconds) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced HEART RATE INCREASED (Rapid heartbeat that lasted for 6 to 10 seconds). At the time of the report, HEART RATE INCREASED (Rapid heartbeat that lasted for 6 to 10 seconds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  No treatment medications provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: Chills; Body ache in both legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Body ache in both legs) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN IN EXTREMITY (Body ache in both legs). On 22-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Body ache in both legs) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided No treatment medications provided
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pruritus, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Back, chest and legs are extremely itchy, "possibly like a rash"; Itchy at the injection site; Really red at the injection site; Swollen at the injection site; Warm to the touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to the touch at the injection site), PRURITUS (Back, chest and legs are extremely itchy, "possibly like a rash"), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Really red at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to the touch at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Really red at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site). On 22-Feb-2021, the patient experienced PRURITUS (Back, chest and legs are extremely itchy, "possibly like a rash"). At the time of the report, INJECTION SITE WARMTH (Warm to the touch at the injection site), PRURITUS (Back, chest and legs are extremely itchy, "possibly like a rash"), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Really red at the injection site) and VACCINATION SITE SWELLING (Swollen at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Benadryl
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness
Clinical narrative: anxious, nervousness; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (anxious, nervousness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension (Patient have blood pressure). Concomitant products included FERROUS SULFATE, METFORMIN, FUROSEMIDE, AMLODIPINE, SIMVASTATIN, CARVEDILOL and RIVAROXABAN (XARELTO) for an unknown indication.    On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced NERVOUSNESS (anxious, nervousness). At the time of the report, NERVOUSNESS (anxious, nervousness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No corrective treatment was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Event Outcome updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Skin infection
Clinical narrative: Rash; skin infection on wrist; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and SKIN INFECTION (skin infection on wrist) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced RASH (Rash) and SKIN INFECTION (skin infection on wrist). At the time of the report, RASH (Rash) and SKIN INFECTION (skin infection on wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included antibiotics and a tetanus shot   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: No new information
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Got a rash; This spontaneous case was reported by a physician and describes the occurrence of RASH (Got a rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Got a rash). At the time of the report, RASH (Got a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Pruritus
Clinical narrative: Swollen arm; Hot arm; Itchy arm; Red arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Hot arm), PRURITUS (Itchy arm) and ERYTHEMA (Red arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Hot arm), PRURITUS (Itchy arm) and ERYTHEMA (Red arm). At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Hot arm), PRURITUS (Itchy arm) and ERYTHEMA (Red arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Vitreous floaters
Clinical narrative: blurred vision; see things on the eye floating; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VISION BLURRED (blurred vision) and VITREOUS FLOATERS (see things on the eye floating) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol (Taking meds for cholesterol) and Blood pressure (Taking meds for blood pressure). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VISION BLURRED (blurred vision) and VITREOUS FLOATERS (see things on the eye floating). At the time of the report, VISION BLURRED (blurred vision) and VITREOUS FLOATERS (see things on the eye floating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 19-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced RASH (Rash on left arm). At the time of the report, RASH (Rash on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment included hydrocortisone cream twice a day
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbing feeling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of HYPOAESTHESIA (Numbing feeling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbing feeling). At the time of the report, HYPOAESTHESIA (Numbing feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain in extremity
Clinical narrative: Flu like ache; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like ache) and PAIN IN EXTREMITY (Sore arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like ache) and PAIN IN EXTREMITY (Sore arm). On 05-Feb-2021, INFLUENZA LIKE ILLNESS (Flu like ache) and PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.    This case was linked to MOD-2021-022642, MOD-2021-021496, MOD-2021-021088 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Upper arm hurts when moved; Itchiness at the injection site; redness at the injection site measuring 1.5 by 1 inches with ragged edges; Soreness at injection site; Injection site warm to the touch; Left arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm hurt), VACCINATION SITE WARMTH (Injection site warm to the touch), PAIN (Upper arm hurts when moved), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site measuring 1.5 by 1 inches with ragged edges) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), SIMVASTATIN and LOSARTAN POTASSIUM (LOSARTIN) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (Left arm hurt). On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm to the touch), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site measuring 1.5 by 1 inches with ragged edges) and VACCINATION SITE PAIN (Soreness at injection site). On 05-Feb-2021, the patient experienced PAIN (Upper arm hurts when moved). At the time of the report, PAIN IN EXTREMITY (Left arm hurt), VACCINATION SITE WARMTH (Injection site warm to the touch), PAIN (Upper arm hurts when moved), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site measuring 1.5 by 1 inches with ragged edges) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment included Advil
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Upper arm hurts when moved; Itchiness at the injection site; redness at the injection site measuring 1.5 by 1 inches with ragged edges; Soreness at injection site; Injection site warm to the touch; Left arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm hurt), VACCINATION SITE WARMTH (Injection site warm to the touch), PAIN (Upper arm hurts when moved), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the injection site measuring 1.5 by 1 inches with ragged edges) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), SIMVASTATIN and LOSARTAN POTASSIUM (LOSARTIN) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (Left arm hurt). On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm to the touch), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site measuring 1.5 by 1 inches with ragged edges) and VACCINATION SITE PAIN (Soreness at injection site). On 05-Feb-2021, the patient experienced PAIN (Upper arm hurts when moved). At the time of the report, PAIN IN EXTREMITY (Left arm hurt), VACCINATION SITE WARMTH (Injection site warm to the touch), PAIN (Upper arm hurts when moved), VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site measuring 1.5 by 1 inches with ragged edges) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment included Advil